MobiHealth News November 1, 2021
Emily Olsen

The study found only 46% of patients eligible for prophylactic low-dose aspirin due to high-risk factors for preeclampsia had gotten a provider recommendation by 16 weeks gestation.

Many pregnant patients who are at high risk for preeclampsia aren’t receiving recommendations for prophylactic low-dose aspirin, but digital tools could facilitate better communication between patients and providers, according to a study published in JAMA Network Open.

The study used the MyHealthyPregnancy app, which was developed by Naima Health. The study’s authors were cofounders or employees of the company.

TOP-LINE DATA

Researchers found only 46% of pregnant patients who were identified as eligible for low-dose aspirin due to reported high risk-factors had received a recommendation from their provider by 16 weeks gestation.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Apps, Digital Health, mHealth, Patient / Consumer, Provider, Survey / Study, Technology, Trends
Why Modern Developers Must Master The Balance Of Privacy And Functionality In Mobile Apps
Concord Technologies Acquires Top-Rated Salesforce App Provider, Opero
Centene boosts medication adherence, lowers Medicaid costs through mobile app: Study
Epic Unveils Expanded APIs for Healthcare App Developers
NHS pilots iPhone app to rule out throat cancer

Share This Article